What to expect

Stopping A Caffeine Capsule: What The Withdrawal Research Says

Most writing about a caffeinated capsule is about starting it. This article is about the other end, because the 60-day guarantee makes stopping a planned event for anybody who decides the bottle is not for them, and because the way caffeine leaves is one of the better-documented things about it. A 2004 critical review pulled the evidence together, and its numbers are specific enough to plan around.

By SlimSet Team · Last updated September 26, 2026 · 9 min read · What to expect

Why an article about stopping belongs before you start

The 60-day guarantee covers opened bottles, and the guarantee page suggests making the decision around day 55. Which means that for a fair number of people, the sequence of events is: take one capsule a day for a month or two, then stop, abruptly, on the day the decision is made. If the thing you stop is a caffeinated capsule, the way it leaves your system is part of the experience, and it is not a small part.

There is a second reason to read it early. Caffeine withdrawal is easy to misread. A day or two after the last capsule you may feel flat, foggy and mildly headachy, and if you have just decided the product did nothing, it is very tempting to conclude that the feeling is about the product. It might be. It is also exactly what a well-characterised pharmacological effect looks like, and it has a schedule. Knowing the schedule lets you tell the two apart.

None of what follows is a criticism of caffeine or of this capsule. Caffeine is one of the most studied compounds in ordinary life. This is simply the part of the profile that only shows when you stop.

What sixty-six studies say withdrawal is

The key source is a critical review by Juliano and Griffiths, published in Psychopharmacology in 2004. They searched the literature and found 57 experimental studies and 9 survey studies of human caffeine withdrawal that met their inclusion criteria, then examined the method of each to decide which reported effects could be trusted.

The starting point was 49 different symptom categories reported across the literature. Of those, ten met the reviewers’ validity criteria: headache, fatigue, decreased energy or activeness, decreased alertness, drowsiness, decreased contentedness, depressed mood, difficulty concentrating, irritability, and feeling foggy or not clear-headed. Three more were judged likely to be valid: flu-like symptoms, nausea or vomiting, and muscle pain or stiffness. The list is worth reading twice, because it is mostly unglamorous. Withdrawal is not dramatic. It is a bad, slow morning that lasts a few days.

The frequencies come from the experimental studies. Headache occurred in 50 per cent of them. Clinically significant distress or functional impairment occurred in 13 per cent. Put plainly: about half of the people who stopped got the headache, and about one in eight had a bad enough time that it interfered with what they needed to do.

The review also asked whether it is all expectation, and reports research indicating that expectancies are not a prime determinant of caffeine withdrawal.

The clock, in hours

What makes the review useful for planning is that it reports timing. Typically, symptoms began 12 to 24 hours after abstinence, reached peak intensity at 20 to 51 hours, and lasted for 2 to 9 days. To make that concrete, here is a single example: a person who takes their last capsule at 7:30 on a Monday morning.

Times are simple arithmetic on the ranges the review reports. The review gives duration as a range without saying whether it counts from onset or from the last dose, so the last row is approximate.

The spread of those ranges is itself informative. A peak between 20 and 51 hours after the last dose means the worst of it can fall on the morning after the day you stopped, or on the day after that, and for a working person it can land on a weekday whichever way you time it. The two-to-nine-day span means some people are through it almost at once and some are still feeling it a week later.

Does 138 mg reach the threshold?

The review makes two points about dose that matter here. First, in general the incidence or severity of symptoms rose as daily intake rose. Second, abstinence from doses as low as 100 mg a day was enough to produce symptoms. One capsule is 138 mg. So the capsule on its own is above the lowest dose at which withdrawal has been reported.

That does not mean stopping the capsule will cause it. What matters is the change in your total, and it helps to work through two people.

Coffee figures are the ordinary-serving estimate used in the caffeine article. The capsule figure is the declared 138 mg and ignores the small extra from the green tea and green coffee rows. These are illustrations of arithmetic, not predictions of symptoms.

The pattern is the point. For the first person, stopping the capsule means stopping caffeine altogether, which is the case the review describes best. For the second, it is a drop of about two-fifths in a day that still contains coffee. For the third, the capsule has been doing the work of a coffee, and stopping removes more than half of what they were used to. Nobody can say from a table how much any individual will feel, but the direction of the risk follows the size of the drop, and the review says exactly that.

Half of people, or a minority?

A careful reader will have noticed that other authoritative sources describe caffeine withdrawal in gentler terms, and it would be a mistake to gloss over that. A 2016 review in Practical Neurology by Nehlig, written for clinicians who need to advise patients, reports that food regulators have judged caffeine not harmful at up to 200 mg in one sitting or 400 mg a day, and concludes that it does not seem to lead to dependence, although a minority of people experience withdrawal symptoms.

The two are not necessarily in contradiction, and the likeliest explanation is that they are counting different things. Juliano and Griffiths were pooling controlled experiments, where volunteers are taken off a regular dose and asked about specific symptoms, and headache came out at 50 per cent. Nehlig is writing for clinicians about the wider public. That reconciliation is this article’s reading, not a claim either paper makes, but it fits the numbers: half is the headache rate in experiments, and the clinically significant distress rate in those same experiments was 13 per cent, closer to a minority.

More recent work has kept confirming the headache in particular. In May 2026, a report in Scientific Reports described a prospective, randomised case-crossover trial in regular caffeinated coffee drinkers and concluded that caffeine avoidance likely contributes to headaches, and that when a headache was present, avoidance was associated with greater severity. The authors point out that earlier work on the question was mostly observational, small, or done in artificial settings, which is what their design was meant to fix.

What this means for judging the capsule

There is a subtler consequence of the withdrawal literature, and it bears directly on the decision the guarantee asks you to make. The reviewers report that avoidance of withdrawal symptoms plays a central role in habitual caffeine consumption. In other words, part of what regular caffeine users experience as the benefit of caffeine is the absence of the withdrawal that would otherwise be there.

For a capsule taken every morning for weeks, that has two implications.

• The lift may be partly relief. After some weeks of a daily 138 mg, a morning without it may feel worse than the morning before you started, and the morning with it may feel like a return to normal rather than an improvement. That is not evidence the capsule is doing something extra. It is evidence that your baseline moved.
• The first days after stopping are a poor time to judge. If you decide on day 55 that the bottle did nothing for you, stop, and feel terrible on day 57, the feeling is a poor guide to what the capsule did. The useful readings are the ones taken before you started and in the weeks when the routine was steady. The results timeline lays out a log that puts those readings on paper.

The same applies to the reverse decision. Reordering because you felt flat on the one morning you forgot the capsule is reordering to avoid withdrawal, which is a reasonable thing to do with your own money but not a finding about the formula. The four botanicals on the panel are a different matter, and the ingredient articles on this blog read them one at a time.

If you decide to stop

The research characterises withdrawal; it does not test ways of managing it, so what follows is the ordinary practical reading and not a protocol anyone has trialled. It also follows the logic on the how to use page, which tells anyone who has cut other coffee to make room for the capsule to expect a headache for two or three days as the total intake falls.

1. Work out your before and after. Total what you drink in a normal day, with the capsule and without, as in the table above. The bigger the drop, the more it is worth planning.
2. Consider stepping down rather than stopping. Replace the capsule with a coffee or tea of roughly similar size for a few days, then reduce that. The aim is to make the drop in daily total smaller, and slower.
3. Time it for a quiet stretch. The peak can fall a day or two after the last capsule, so a Friday capsule that ends on a Monday morning meeting is not ideal.
4. Expect the ordinary list. Headache, tiredness, low mood, poor concentration and irritability are the validated symptoms. Recognising them as such can take the sting out.
5. Know when it is not withdrawal. A headache that is severe, sudden, unlike your usual ones, or accompanied by other symptoms is a reason to see a healthcare professional and not to assume it is caffeine.
6. Mind the guarantee clock. The window is 60 days from purchase and the desk needs time to issue a return authorisation, which is why the guarantee page suggests deciding around day 55. Do not let a withdrawal headache on day 58 rush a decision you would have made differently.

Limits of the evidence

A few honest caveats belong at the end. The 2004 review pools studies of many designs, and none of them was a study of this product. Nobody has studied withdrawal from a capsule with four botanicals alongside the caffeine. The 50 per cent headache figure comes from experimental settings, not from people quietly cutting back. The 2026 trial looked at coffee drinkers and at headache, not at the full symptom list, and its abstract gives no numbers to quote.

What all of that leaves is a clear and reasonably modest set of facts. Caffeine leaves on a schedule, the schedule is known, the size of the effect follows the size of the drop, and the person best placed to plan for it is the one who has read it before the first capsule.

References